Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Natasha Lapteva"'
Autor:
Cliona M. Rooney, Claudia Rossig, Ann M. Leen, Paul R. Kinchington, Gianpietro Dotti, Birju Mehta, Minhtran Ngo, Jun Ando, Natasha Lapteva, Bilal Omer, Haruko Tashiro, Miyuki Tanaka
Supplementary Figure 1(A) VZVSTs were generated from vaccinated healthy donors (n=3) at three time points (Pre-vaccination, 1 week after and 2 weeks after vaccination); Supplementary Figure 2 (A) GD2.CAR-VZVST were cocultured with GFPffluc-LAN1 at 1:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60bd0b7284a41561e7d152c58bd73ca2
https://doi.org/10.1158/1078-0432.22466357.v1
https://doi.org/10.1158/1078-0432.22466357.v1
Autor:
Cliona M. Rooney, Claudia Rossig, Ann M. Leen, Paul R. Kinchington, Gianpietro Dotti, Birju Mehta, Minhtran Ngo, Jun Ando, Natasha Lapteva, Bilal Omer, Haruko Tashiro, Miyuki Tanaka
Supplement methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf1340ce5c3e4a465a027ec23e40bad
https://doi.org/10.1158/1078-0432.22466363.v1
https://doi.org/10.1158/1078-0432.22466363.v1
Autor:
Cliona M. Rooney, Claudia Rossig, Ann M. Leen, Paul R. Kinchington, Gianpietro Dotti, Birju Mehta, Minhtran Ngo, Jun Ando, Natasha Lapteva, Bilal Omer, Haruko Tashiro, Miyuki Tanaka
Supplementary figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463db3217815cc8e148b0e5025ac754c
https://doi.org/10.1158/1078-0432.22466360.v1
https://doi.org/10.1158/1078-0432.22466360.v1
Autor:
Cliona M. Rooney, Claudia Rossig, Ann M. Leen, Paul R. Kinchington, Gianpietro Dotti, Birju Mehta, Minhtran Ngo, Jun Ando, Natasha Lapteva, Bilal Omer, Haruko Tashiro, Miyuki Tanaka
Purpose: The multiple mechanisms used by solid tumors to suppress tumor-specific immune responses are a major barrier to the success of adoptively transferred tumor-specific T cells. As viruses induce potent innate and adaptive immune responses, we h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a803952db20832c460910a08d7a703c9
https://doi.org/10.1158/1078-0432.c.6526298.v1
https://doi.org/10.1158/1078-0432.c.6526298.v1
Autor:
Meenakshi Hegde, Shoba Navai, Christpher DeRenzo, Sujith Joseph, Khaled Sanber, Meng-Fen Wu, Katherine Janeway, Ahmed Gad, Matthew Campbell, Dolores Mullikin, Zeid Nawas, Catherine Robertson, Pretty Matthew, Huimin Zhang, Birju Mehta, Ankita Shree, Claudia Gerken, Mamta Kalra, Rikhia Chakraborty, Sachin Thakar, Olga Dakhova, Vita Salsman, Bambi Grilley, Natasha Lapteva, Adrian Gee, Gianpietro Dotti, Wang Tao, John Hicks, Malcolm Brenner, Helen Heslop, Winfried Wels, Stephen Gottschalk, Nabil Ahmed
Purpose To determine the maximum tolerated dose (MTD) of autologous chimeric antigen receptor T cells (HER2-CART) after lymphodepletion and to describe the cellular kinetics, safety, feasibility of repeat treatment cycles, and antitumor activity of H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73bd02af4069667f464686f1bf74bf5c
https://doi.org/10.21203/rs.3.rs-2409436/v1
https://doi.org/10.21203/rs.3.rs-2409436/v1
Autor:
Paul R. Kinchington, Ann M. Leen, Miyuki Tanaka, Jun Ando, Haruko Tashiro, Natasha Lapteva, Birju Mehta, Cliona M. Rooney, Bilal Omer, Gianpietro Dotti, Minhtran C. Ngo, Claudia Rossig
Publikováno v:
Clinical Cancer Research. 23:3499-3509
Purpose: The multiple mechanisms used by solid tumors to suppress tumor-specific immune responses are a major barrier to the success of adoptively transferred tumor-specific T cells. As viruses induce potent innate and adaptive immune responses, we h
Autor:
Mamatha Seethammagari, John McMannis, David M. Spencer, Kevin M. Slawin, Annemarie Moseley, Guru Sonpavde, Joan M C Bull, Theresa K. Dancsak, Natasha Lapteva, Victoria E Hawkins, Yu Bai, Jonathan M. Levitt
Publikováno v:
Cancer Immunology, Immunotherapy. 66:1345-1357
This phase I trial reports the safety and activity of BPX101, a second-generation antigen-targeted autologous antigen presenting cell (APC) vaccine in men with metastatic castration-resistant prostate cancer (mCRPC). To manufacture BPX101, APCs colle
Publikováno v:
Molecular Therapy. 26:6-7
Autor:
Silvana Perconti, Natasha Lapteva, Cliona M. Rooney, Malcolm K. Brenner, Adrian P. Gee, N. Shah, A. Reyna, J. Castello, Helen E. Heslop, Carlos A. Ramos, Sandhya Sharma, Rayne H. Rouce, Mary K. McKenna, Aarohi Thakkar, Premal Lulla, Birju Mehta, Huimin Zhang
Publikováno v:
Cytotherapy. 21:e3
Background & Aim Given the efficacy of donor-derived EBV-specific T cells (EBVSTs) in the post- HSCT environment, and considering many lymphoma patients are immunocompromised, we hypothesized that third-party EBVSTs can effectively treat EBV+ lymphom
Autor:
Margaret Gilbert, Adrian P. Gee, Manasa Hiregange, Robert A. Krance, Hao Liu, Iulia Diaconu, Lisa Rollins, Cliona M. Rooney, Rayne H. Rouce, Carlos A. Ramos, Natasha Lapteva, Helen E. Heslop, Olga Dakhova, April G. Durett, Barbara Savoldo
Publikováno v:
Cytotherapy. 18:S9-S10